Non-invasive Prenatal Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
The non-invasive prenatal diagnostics market is expected to grow in the forecast period owing to key factors such as rise in the population, increase in the demand for the non-invasive prenatal diagnostic testing products and others. The market is likely to experience the growth opportunities in the emerging nations and the technological advancements are likely to develop innovative products.
The "Global Non-invasive Prenatal Diagnostics Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global non-invasive prenatal diagnostics market with detailed market segmentation by product, application, end user and geography. The global non-invasive prenatal diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Non-invasive prenatal diagnostics market players and offers key trends and opportunities in the market.
The global non-invasive prenatal diagnostics market is segmented on the basis of product, application and end user. Based product, the market is segmented as instruments and consumables. On the basis of the application the market segmentation is classified as microdeletion syndrome, trisomy and others. Based on the end user the market is segmented as hospitals, diagnostics laboratories and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global non-invasive prenatal diagnostics market based on product, application and end user. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-invasive prenatal diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the non-invasive prenatal diagnostics market in the forecast period. Asia Pacific is anticipated to be the fastest growing region due to the increasing number of pregnancies, increasing risk of premature deliveries due to unhealthy lifestyle and increase in the demand of the NIPT products.
The report analyzes factors affecting non-invasive prenatal diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-invasive prenatal diagnostics market in these regions.
The report also includes the profiles of key non-invasive prenatal diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the non-invasive prenatal diagnostics market include, Thermo Fisher Scientific, Inc., Illumina, Inc., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen, F. Hoffmann-La Roche Ltd, BGI, Agilent Technologies, Inc., Eurofins Scientific and Quest Diagnostics Incorporated. REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Non-invasive Prenatal Diagnostics Market- By Product
1.3.2. Non-invasive Prenatal Diagnostics Market- By Application
1.3.3. Non-invasive Prenatal Diagnostics Market- By End User
1.3.4. Non-invasive Prenatal Diagnostics Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NONINVASIVE PRENATAL DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET- GLOBAL ANALYSIS
6.1. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET - GLOBAL MARKET OVERVIEW
6.2. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS MARKET
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis (US$ Mn)
7.3.3. Ultrasound Devices Market
7.3.3.1. Overview
7.3.3.2. Ultrasound Devices Market Forecast and Analysis (US$ Mn)
7.3.4. NGS Systems Market
7.3.4.1. Overview
7.3.4.2. NGS Systems Market Forecast and Analysis (US$ Mn)
7.3.5. PCR Instruments Market
7.3.5.1. Overview
7.3.5.2. PCR Instruments Market Forecast and Analysis (US$ Mn)
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis (US$ Mn)
7.4. CONSUMABLES MARKET
7.4.1. Overview
7.4.2. Consumables Forecast and Analysis (US$ Mn)
8. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MICRODELETION SYNDROME MARKET
8.3.1. Overview
8.3.2. Microdeletion Syndrome Market Forecast and Analysis (US$ Mn)
8.4. TRISOMY MARKET
8.4.1. Overview
8.4.2. Trisomy Market Forecast and Analysis (US$ Mn)
8.5. OTHERS MARKET
8.5.1. Overview
8.5.2. Others Modelling Market Forecast and Analysis (US$ Mn)
9. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS MARKET
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis (US$ Mn)
9.4. DIAGNOSTIC LABORATORIES MARKET
9.4.1. Overview
9.4.2. Diagnostic Laboratories Market Forecast and Analysis (US$ Mn)
9.5. OTHERS MARKET
9.5.1. Overview
9.5.2. Others Modelling Market Forecast and Analysis (US$ Mn)
?
10. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.1.1. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.3. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.4. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.5. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.6.2. US Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.6.3. US Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.7.2. Canada Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7.3. Canada Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.8.2. Mexico Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8.3. Mexico Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2. EUROPE NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.2.1. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.3. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.4. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.5. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.6.2. UK Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.6.3. UK Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.7.2. Germany Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7.3. Germany Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.8.2. France Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8.3. France Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.9.2. Italy Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.9.3. Italy Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.10.2. Spain Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.10.3. Spain Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3. ASIA PACIFIC NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.3.1. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.3. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.4. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.5. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.6.2. Japan Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.6.3. Japan Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.7. India Market Overview
10.3.7.1. India Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.7.2. India Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7.3. India Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.8. China Market Overview
10.3.8.1. China Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.8.2. China Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8.3. China Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.9.2. South Korea Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.9.3. South Korea Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.10.2. Australia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.10.3. Australia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.4.1. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.3. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.4. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.5. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.6.2. South Africa Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.6.3. South Africa Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.7.2. Saudi Arabia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7.3. Saudi Arabia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.8.2. UAE Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8.3. UAE Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.5.1. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.3. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.4. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.5.5. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.6.2. Brazil Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.6.3. Brazil Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.7.2. Argentina Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.7.3. Argentina Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions
12. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product/Service Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ILLUMINA, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product/Service Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PACIFIC BIOSCIENCIES OF CALIFORNIA, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product/Service Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PERKIN ELMER, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product/Service Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. QIAGEN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product/Service Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCJE LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product/Service Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BGI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product/Service Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AGILENT TECHNOLOGIES, INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product/Service Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EUROFINS SCIENTIFIC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product/Service Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. QUEST DIAGNOSTICS INCORPORATED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product/Service Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
NOTE:
• This ToC is tentative in nature and is subject to further refinement during the course of the research study
• The list of company profiles included in this ToC is tentative. Profiles of specific players, if required, shall be added to the report upon request.
• Financials can be provided to the extent of availability in the public domain.
1. Thermo Fisher Scientific, Inc.
2. Illumina, Inc.
3. Pacific Biosciences of California, Inc.
4. Perkinelmer, Inc.
5. QIAGEN
6. F. Hoffmann-La Roche Ltd
7. BGI
8. Agilent Technologies, Inc.
9. Eurofins Scientific
10. Quest Diagnostics Incorporated
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For